- Home
- OMEX vs IBIO Comparison
OMEX vs IBIO Comparison
Compare OMEX & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMEX | IBIO |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.2M | 84.6M |
| IPO Year | 2024 | 2009 |
Fundamental Metrics
Financial Performance| Metric | OMEX | IBIO |
|---|---|---|
| Price | $1.39 | $2.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.75 |
| AVG Volume (30 Days) | 433.3K | ★ 937.0K |
| Earning Date | 03-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,327.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $0.56 |
| 52 Week High | $4.43 | $4.86 |
Technical Indicators
Market Signals| Indicator | OMEX | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.85 | 37.85 |
| Support Level | $1.25 | $2.02 |
| Resistance Level | $1.75 | $3.01 |
| Average True Range (ATR) | 0.11 | 0.25 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 11.11 | 13.13 |
Price Performance
Historical ComparisonAbout OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.